About Ideal Cures
Ideal Cures is a Healthcare company based in Mumbai (India) founded in 1999, and was acquired by Colorcon in October 2021. Manufacturer of pharmaceutical excipients and coatings systems for solid oral dosage forms. The company has 241 employees. Its Indian entity Ideal Cures Private Limited reported revenue of ₹240 Cr. Its focus areas include Biopharma Outsourcing, Logistics & Supply Chain and Packaging. Its competitors include SCHOTT Poonawalla, Natural Capsules and Cilicant; 1 of its 3 listed competitors has raised funding.
Company details
Ideal Cures was founded in 1999 and is based in Mumbai, India. Operations focus on the pharmaceutical sector, where excipients and coating systems for solid oral dosage forms are produced. Manufacturing processes are centered on these specialized materials, supporting drug formulation needs. The company maintains a presence in the Indian pharmaceutical industry, with key leadership provided by Managing Director Maulek Desai.
- Headquarters Mumbai, India
- Employees 241
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website idealcures.com
- Social LinkedIn X Facebook
- Acquired by Colorcon (Oct 2021)
- Legal Name Ideal Cures Private Limited
- Date of Incorporation 18 Jul, 1988
- Jurisdiction Mumbai, Maharashtra, India
Associated legal entities of Ideal Cures
Ideal Cures is associated with 2 registered companies on The Company Check; the primary company is Ideal Cures Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ideal Cures Private Limited CIN U24239MH1988PTC048150 | Active | 18 Jul 1988 | Mumbai, Maharashtra | ₹240 Cr | 241 | 4 | View details |
| Ideal Cures (Sikkim) Private Limited CIN U24100MH2009PTC286920 | Amalgamated | 05 Jan 2009 | Mumbai, Maharashtra | ₹0.1 Cr | 17 | 3 | View details |
Funding Insights of Ideal Cures
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of Ideal Cures with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2017 | Private Equity Round | – | TA | – | |
| Sep 2004 | Unspecified | – | rsglobalinfotech.co.uk | – |
3 investors in total: 3 institutional.
Investors in Ideal Cures
Ideal Cures has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Colorcon, TA Associates and rsglobalinfotech.co.uk.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are invested in by private equity firm TA. | ta.com | Boston, United States | ||
Developer of specialty excipients and corporate-backed venture capital fund focused on healthcare startups | 1961 | colorcon.com | Harleysville, United States | |
| rsglobalinfotech.co.uk |
Investor details for Ideal Cures
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ideal Cures Private Limited (Ideal Cures)
Ideal Cures Private Limited is the primary company behind Ideal Cures. The boards of the 2 registered companies of Ideal Cures currently have 6 directors; the longest-serving is Dinesh Kumar Pareek, appointed in 2016. 23 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dinesh Kumar Pareek DIN 02482456 | Director | 24 Feb 2016 | 10 yrs 8 mo | Ideal Cures (Sikkim) Private Limited |
| Veena Suresh Pareek DIN 00756339 | Director | 24 Feb 2016 | 10 yrs 8 mo | Ideal Cures (Sikkim) Private Limited |
| Suresh Rukmanand Pareek DIN 00757066 | Director | 24 Feb 2016 | 10 yrs 8 mo | Ideal Cures (Sikkim) Private Limited |
| Dinesh Laxminarayan Pandey DIN 09812355 | Company Secretary | 01 Nov 2016 | 10 yrs | Ideal Cures Private Limited |
| Maulek Jawaharlal Desai DIN 10561569 | Managing Director | 01 Apr 2024 | 2 yrs 7 mo | Ideal Cures Private Limited |
| Anita Shekhar Dhande DIN 10041490 | Additional Director | 29 Aug 2025 | 1 yr 2 mo | Ideal Cures Private Limited |
People of Ideal Cures
11 people are tracked at Ideal Cures (8 in leadership, 3 in team); the tracked headcount is 241.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership | |
Sanjeev Pathak | General Manager Human Resources | Leadership |
Kirankumar Patil | General Manager Supply Chain | Leadership |
Dr. Maulek J Desai | General Manager | Leadership |
Rohan Rastogi | Global Marketing Director | Leadership |
| CEO | Leadership | |
Piraj Singh | Plant Head | Leadership |
Kiran Sawant | Business And Technical Head - Polymer | Leadership |
Tanvi Sawant | Technical Manager | Team |
Rahul Patole | Key Account Manager | Team |
Priyanka Pathak | Regulatory Affairs Executive | Team |
Complete people profiles for Ideal Cures
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Ideal Cures
Figures of Ideal Cures Private Limited, the primary company behind Ideal Cures, for FY 2025. Revenue was ₹240 Cr (+6% year on year). Net profit was ₹85.77 Cr (36% margin). EBITDA was ₹107 Cr (45% margin). Revenue has grown at a compounded annual rate of +10% over five years.
- ₹240 CrRevenue · FY 2025 · +6% YoY
- ₹85.77 CrNet profit · 36% margin
- ₹107 CrEBITDA · 45% margin
- ₹7.50 CrPaid-up capital
- 241Employees (provident fund records)
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ideal Cures Private Limited are on its company page.
Detailed financial statements for Ideal Cures
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Ideal Cures
4 dated milestones of Ideal Cures across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Ideal Cures is founded.
- Funding First funding round.
- Funding Latest funding round, Private Equity Round,.
- Exit Acquired by Colorcon.
Competitors of Ideal Cures
Ideal Cures has 3 listed competitors in our database, 1 of them funded. They include SCHOTT Poonawalla, Natural Capsules and Cilicant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| schott-poonawalla.com | 1990 | Mumbai, India | 1,297 | Packaging solutions for pharmaceutical and biotech industries are provided. | ||
| naturalcapsules.com | 1993 | Bengaluru, India | 99 | Manufacturing and supply chain services for biopharma sector are provided. | ||
| cilicant.com | 2011 | Pune, India | $2M | 283 | Drugs for the biopharma sector are manufactured and supplied. |
Detailed competitors of Ideal Cures
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ideal Cures
The website of Ideal Cures (idealcures.com) receives about 1K visits a month.
- Monthly visits1K
▲ 16.8% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Ideal Cures (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ideal Cures
Complete news archive for Ideal Cures
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ideal Cures
Ideal Cures was founded in 1999 and raised its 1st funding round 5 years after it was founded.
Ideal Cures is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Ideal Cures has 241 employees.
The primary company behind Ideal Cures, Ideal Cures Private Limited, reported revenue of ₹240 Cr for FY 2025, up 6% year on year.
Ideal Cures was founded in 1999 and is based in Mumbai, India. Operations focus on the pharmaceutical sector, where excipients and coating systems for solid oral dosage forms are produced. Manufacturing processes are centered on these specialized materials, supporting drug formulation needs. The company maintains a presence in the Indian pharmaceutical industry, with key leadership provided by Managing Director Maulek Desai.
Ideal Cures's top competitors include Natural Capsules, SCHOTT Poonawalla and Cilicant.
Ideal Cures has 3 investors. Key investors include Colorcon, TA Associates, and rsglobalinfotech.co.uk.
Ideal Cures is associated with 2 legal entities: Ideal Cures Private Limited, Ideal Cures (Sikkim) Private Limited.
Yes. Ideal Cures was acquired by Colorcon in October 2021.
The legal entities of Ideal Cures currently have 6 directors, including Maulek Jawaharlal Desai, Dinesh Laxminarayan Pandey, Anita Shekhar Dhande and others.